- Home
- VNRX vs NMTC Comparison
VNRX vs NMTC Comparison
Compare VNRX & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VNRX | NMTC |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.2M | 31.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VNRX | NMTC |
|---|---|---|
| Price | $0.28 | $0.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $3.17 | $2.23 |
| AVG Volume (30 Days) | ★ 2.6M | 130.0K |
| Earning Date | 11-13-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,472,007.00 | ★ $6,629,051.00 |
| Revenue This Year | $55.33 | $162.84 |
| Revenue Next Year | $493.79 | $26.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 14.48 | ★ 69.00 |
| 52 Week Low | $0.27 | $0.40 |
| 52 Week High | $0.94 | $1.39 |
Technical Indicators
Market Signals| Indicator | VNRX | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 32.86 | 36.19 |
| Support Level | $0.28 | $0.66 |
| Resistance Level | $0.34 | $0.75 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 11.30 | 4.00 |
Price Performance
Historical ComparisonAbout VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.